Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06748885

Mpact 3D Metal Monolit Study

Prospective, Multicentre, Non-randomised, Open Study Evaluating the Efficacy and Fixation of the Mpact 3D Metal Monolit Cup

Status
Recruiting
Phase
Study type
Observational
Enrollment
88 (estimated)
Sponsor
Medacta International SA · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life. Surgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure. In recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation. The current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.

Conditions

Interventions

TypeNameDescription
DEVICEMpact 3D Metal MonolithTHA with Mpact 3D Metal Monolith

Timeline

Start date
2024-02-28
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2024-12-27
Last updated
2024-12-27

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06748885. Inclusion in this directory is not an endorsement.